Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study

SIMPLE SUMMARY: Despite the emergence of new therapies during the last decade, metastatic castration-resistant prostate cancer (mCRPC) remains fatal. Recent work showed that the timing of treatment initiation seems critical for patient outcomes. Thus, it is key to identify factors that can help in d...

詳細記述

保存先:
書誌詳細
出版年:Cancers (Basel)
主要な著者: Delanoy, Nicolas, Robbrecht, Debbie, Eisenberger, Mario, Sartor, Oliver, de Wit, Ronald, Mercier, Florence, Geffriaud-Ricouard, Christine, de Bono, Johann, Oudard, Stéphane
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2021
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8002173/
https://ncbi.nlm.nih.gov/pubmed/33805793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061284
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料